https://www.fredhutch.org/en/news/releases/rss2016-10-14T18:17:45.135ZNews Releases RSS FeedAdobe Experience ManagerPhysician-scientist Dr. Bruce Clurman named executive vice president and deputy director of Fred Hutchhttps://www.fredhutch.org/en/news/releases/2016/10/Physician-scientist-Dr-Bruce-Clurman-named-executive-vice-president-and-deputy-director-of-Fred-Hutch2016-10-18T16:15:36.000Z2016-10-18T16:15:36.000ZDr. Nancy Davidson of U Pitt to lead clinical oncology for Fred Hutch / University of Washington Cancer Consortiumhttps://www.fredhutch.org/en/news/releases/2016/10/Nancy-Davidson-to-lead-Fred-Hutch-UW-Cancer-Consortium2016-10-10T16:43:06.000Z2016-10-10T16:43:06.000ZFred Hutch selected to join national effort to transform treatment for pancreatic cancer patientshttps://www.fredhutch.org/en/news/releases/2016/10/Fred-Hutch-selected-to-join-national-effort-to-transform-treatment-for-pancreatic-cancer-patients2016-10-05T00:13:56.000Z2016-10-05T00:13:56.000ZFred Hutch researchers Jesse Bloom and Frederick Matsen selected as Howard Hughes Medical Institute Faculty Scholarshttps://www.fredhutch.org/en/news/releases/2016/09/Hutch-researchers-selected-as-Howard-Hughes-Medical-Institute-Faculty-Scholars2016-09-22T20:53:09.000Z2016-09-22T20:53:09.000ZFor high-risk leukemia patients, umbilical cord blood transplant associated with lower risk of relapsehttps://www.fredhutch.org/en/news/releases/2016/09/Umbilical-cord-blood-transplant-is-associated-with-high-survival-rate-among-high-risk-leukemia-patients2016-09-07T20:49:51.000Z2016-09-07T20:49:51.000ZJCAR014 clinical data published in Science Translational Medicine: Patients with advanced lymphoma in remission after T-cell therapyhttps://www.fredhutch.org/en/news/releases/2016/09/Patients-with-advanced-lymphoma-in-remission-after-T-cell-therapy2016-09-07T19:16:25.000Z2016-09-07T19:16:25.000ZBone marrow transplant patients report better quality of life compared to peripheral blood transplant recipients from unrelated volunteer donorshttps://www.fredhutch.org/en/news/releases/2016/08/bone-marrow-transplant-patients-report-better-quality-of-life-co2016-08-16T18:11:28.000Z2016-08-16T18:11:28.000ZA record number of riders pedal in Fred Hutch’s Obliteride this weekendhttps://www.fredhutch.org/en/news/releases/2016/08/a-record-number-of-riders-pedal-in-fred-hutchs-obliteride-this-w2016-08-10T19:11:25.000Z2016-08-10T19:11:25.000ZFred Hutch’s Obliteride Rolls Through Dozens of Northwest Communitieshttps://www.fredhutch.org/en/news/releases/2016/08/fred-hutch_s-obliteride-rolls-through-dozens-of-northwest-commun2016-08-02T22:25:40.000Z2016-08-02T22:25:40.000ZDeFeatHIV receives second five-year grant from NIH to research gene and cell therapiesDefeatHIV receives second five-year grant from NIH to research gene and cell therapies. The funding allows Fred Hutch’s HIV cure program to both extend and expand.https://www.fredhutch.org/en/news/releases/2016/07/defeat-hiv-second-five-year-grant-gene-cell-therapies2016-07-13T19:52:59.000Z2016-07-13T19:52:59.000ZFred Hutchinson Cancer Research Center appoints FY 2016-17 board members, including Microsoft CEO Satya Nadella Fred Hutch appoints FY 2016-17 board members, including Microsoft CEO Satya Nadella. Former Washington Gov. Christine Gregoire appointed as board chair to lead innovative group of business and health leaders.https://www.fredhutch.org/en/news/releases/2016/07/Fred-Hutch-appoints-board-members-including-Microsoft-CEO-Satya-Nadella2016-07-11T10:00:00.000Z2016-07-11T10:00:00.000ZFred Hutch medical tipsheet for JulyFred Hutch medical tipsheet for July - Cancer Moonshot, global health, HIV vaccinehttps://www.fredhutch.org/en/news/releases/2016/07/fred-hutch-medical-tipsheet-july2016-07-07T17:54:26.000Z2016-07-07T17:54:26.000ZTesting for inherited mutations could benefit men with advanced prostate cancerInherited mutations in genes that function to repair DNA may contribute to metastatic prostate cancer more than previously recognized, according to a study out today in The New England Journal of Medicine. Though infrequent in the general population, inherited mutations in specific types of DNA repair genes, such as BRCA1 and BRCA2, are known to predispose to prostate cancer.https://www.fredhutch.org/en/news/releases/2016/07/men-with-advanced-prostate-cancer-may-benefit-from-testing-for-inherited-mutations2016-07-06T21:00:00.000Z2016-07-06T21:00:00.000ZDr. Anne McTiernan named to HHS 2018 Physical Activity Guidelines Advisory CommitteeDr. Anne McTiernan, a breast cancer epidemiologist and cancer prevention expert at Fred Hutchinson Cancer Research Center, has been appointed to the 2018 Physical Guidelines Advisory Committee of the U.S. Department of Health and Human Services. She is among 17 nationally recognized experts in physical activity and health to serve on the committee, announced today by Dr. Karen DeSalvo, HHS assistant secretary for health.https://www.fredhutch.org/en/news/releases/2016/07/anne-mctiernan-named-to-HHS-activity-guidelines-committee2016-06-29T18:24:56.000Z2016-06-29T18:24:56.000ZNovel study in Nairobi infants may accelerate path to HIV vaccineThe first and only study to look at isolate HIV-neutralizing antibodies from infants has found that novel antibodies that could protect against many variants of HIV can be produced relatively quickly after infection compared to adults. This suggests that various aspects of HIV-vaccine development, from design to administration, could be improved by mimicking infection and immune response in infants. https://www.fredhutch.org/en/news/releases/2016/07/study-in-nairobi-infants-may-accelerate-path-hiv-vaccine2016-06-23T18:06:29.000Z2016-06-23T18:06:29.000ZTelephone-based cognitive behavioral therapy significantly improves menopause symptomsChatting on the phone with a “sleep coach” and keeping a nightly sleep diary significantly improve sleep quality and reduce insomnia in women through all stages of menopause, according to a new study published today in JAMA Internal Medicine. The study also found that such phone-based cognitive behavioral therapy significantly reduced the degree to which hot flashes, or vasomotor symptoms, interfered with daily functioning.
https://www.fredhutch.org/en/news/releases/2016/05/phone-based-therapy-improve-menopause-symptoms2016-05-23T15:00:00.000Z2016-05-23T15:00:00.000ZFred Hutch hires Steve Stadum as executive vice president and chief operating officerFred Hutchinson Cancer Research Center today announced the hiring of Steve Stadum as executive vice president and chief operating officer. Stadum, currently the chief operating officer of Oregon Health & Science University’s Knight Cancer Institute, played a central role in securing $1 billion in financing to launch a vast expansion of the Portland-based institute. On July 5, he will join Fred Hutch as a key member of President and Director Dr. Gary Gilliland’s staff.
https://www.fredhutch.org/en/news/releases/2016/04/steve-stadum-new-fred-hutch-evp-and-coo2016-04-29T18:28:06.000Z2016-04-29T18:28:06.000ZFred Hutch President and Director Gary Gilliland elected to American Academy of Arts and Sciences Dr. Gary Gilliland, president and director of Fred Hutchinson Cancer Research Center, has been elected to membership in the American Academy of Arts and Sciences, one of the nation’s oldest and most prestigious honorary societies and independent policy-research centers.https://www.fredhutch.org/en/news/releases/2016/04/gary-gilliland-elected-american-academy-arts-sciences2016-04-20T08:30:00.000Z2016-04-20T08:30:00.000ZFred Hutch's Obliteride lights the sky orange to help cure cancer fasterStarting today – coinciding with Vice President Joe Biden’s visit to Fred Hutchinson Cancer Research Center to discuss the cancer “moonshot”– and running through April 8, Obliteride’s supporters and partners will light the Seattle skyline orange to show their commitment to help Fred Hutch cure cancer. The Pacific Science Center arches, The Great Wheel, REI climbing rock, Columbia Tower, IBM Plaza and Union Square are just a few of the structures turning “Obliteride orange.”https://www.fredhutch.org/en/news/releases/2016/03/obliteride-lights-sky-orange2016-03-21T17:29:14.000Z2016-03-21T17:29:14.000ZFred Hutch researcher receives grant for esophageal cancer screening studyDr. William Grady, a clinical researcher and cancer geneticist at Fred Hutch, has been awarded a $180,000 grant from the DeGregorio Family Foundation for Gastric and Esophageal Cancer Research and the Price Family Foundation for a two-year project to develop a better way to identify people at highest risk for esophageal adenocarcinoma, the most common cancer of the esophagus. https://www.fredhutch.org/en/news/releases/2016/03/hutch-researcher-gets-grant-for-esophageal-cancer-screening-study2016-03-10T19:44:37.000Z2016-03-10T19:44:37.000Z